BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38290087)

  • 1. mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b.
    Uehara K; Lee WD; Stefkovich M; Biswas D; Santoleri D; Garcia Whitlock A; Quinn W; Coopersmith T; Creasy KT; Rader DJ; Sakamoto K; Rabinowitz JD; Titchenell PM
    J Clin Invest; 2024 Jan; 134(7):. PubMed ID: 38290087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis.
    Mehta MB; Shewale SV; Sequeira RN; Millar JS; Hand NJ; Rader DJ
    J Biol Chem; 2017 Jun; 292(25):10444-10454. PubMed ID: 28473467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis.
    Luo X; Zhang Y; Ruan X; Jiang X; Zhu L; Wang X; Ding Q; Liu W; Pan Y; Wang Z; Chen Y
    Diabetes; 2011 May; 60(5):1435-45. PubMed ID: 21471512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protein Phosphatase 1 Complex Is a Direct Target of AKT that Links Insulin Signaling to Hepatic Glycogen Deposition.
    Li Q; Zhao Q; Zhang J; Zhou L; Zhang W; Chua B; Chen Y; Xu L; Li P
    Cell Rep; 2019 Sep; 28(13):3406-3422.e7. PubMed ID: 31553910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glucose homeostasis and lipid metabolism by PPP1R3G-mediated hepatic glycogenesis.
    Zhang Y; Xu D; Huang H; Chen S; Wang L; Zhu L; Jiang X; Ruan X; Luo X; Cao P; Liu W; Pan Y; Wang Z; Chen Y
    Mol Endocrinol; 2014 Jan; 28(1):116-26. PubMed ID: 24264575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin.
    Byles V; Cormerais Y; Kalafut K; Barrera V; Hughes Hallett JE; Sui SH; Asara JM; Adams CM; Hoxhaj G; Ben-Sahra I; Manning BD
    Mol Metab; 2021 Nov; 53():101309. PubMed ID: 34303878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalent role of the insulin receptor isoform A in the regulation of hepatic glycogen metabolism in hepatocytes and in mice.
    Diaz-Castroverde S; Baos S; Luque M; Di Scala M; González-Aseguinolaza G; Gómez-Hernández A; Beneit N; Escribano O; Benito M
    Diabetologia; 2016 Dec; 59(12):2702-2710. PubMed ID: 27600278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hepatic PKCβ in nutritional regulation of hepatic glycogen synthesis.
    Shu Y; Hassan F; Ostrowski MC; Mehta KD
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronarin A modulated hepatic glycogen synthesis and gluconeogenesis via inhibiting mTORC1/S6K1 signaling and ameliorated glucose homeostasis of diabetic mice.
    Huang SL; Xie W; Ye YL; Liu J; Qu H; Shen Y; Xu TF; Zhao ZH; Shi Y; Shen JH; Leng Y
    Acta Pharmacol Sin; 2023 Mar; 44(3):596-609. PubMed ID: 36085523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis.
    Uehara K; Sostre-Colón J; Gavin M; Santoleri D; Leonard KA; Jacobs RL; Titchenell PM
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1625-1647. PubMed ID: 35240344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
    Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
    Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pacer Is a Mediator of mTORC1 and GSK3-TIP60 Signaling in Regulation of Autophagosome Maturation and Lipid Metabolism.
    Cheng X; Ma X; Zhu Q; Song D; Ding X; Li L; Jiang X; Wang X; Tian R; Su H; Shen Z; Chen S; Liu T; Gong W; Liu W; Sun Q
    Mol Cell; 2019 Feb; 73(4):788-802.e7. PubMed ID: 30704899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic p53 is regulated by transcription factor FOXO1 and acutely controls glycogen homeostasis.
    Oster M; Galhuber M; Krstic J; Steinhoff JS; Lenihan-Geels G; Wulff S; Kiefer MF; Petricek KM; Wowro SJ; Flores RE; Yang N; Li C; Meng Y; Reinisch I; Sommerfeld M; Weger S; Habisch H; Madl T; Schulz TJ; Prokesch A; Schupp M
    J Biol Chem; 2022 Sep; 298(9):102287. PubMed ID: 35868560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.
    Kir S; Beddow SA; Samuel VT; Miller P; Previs SF; Suino-Powell K; Xu HE; Shulman GI; Kliewer SA; Mangelsdorf DJ
    Science; 2011 Mar; 331(6024):1621-4. PubMed ID: 21436455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactivation of hepatic mechanistic target of rapamycin kinase complex 1 (mTORC1) is associated with low transcriptional activity of transcription factor EB and lysosomal dysfunction in dairy cows with clinical ketosis.
    Fang Z; Li X; Wang S; Jiang Q; Loor JJ; Jiang X; Ju L; Yu H; Shen T; Chen M; Song Y; Wang Z; Du X; Liu G
    J Dairy Sci; 2022 May; 105(5):4520-4533. PubMed ID: 35248377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib.
    Krishnamurthy KA; Rutten MGS; Hoogerland JA; van Dijk TH; Bos T; Koehorst M; de Vries MP; Kloosterhuis NJ; Havinga H; Schomakers BV; van Weeghel M; Wolters JC; Bakker BM; Oosterveer MH
    Mol Metab; 2024 Jan; 79():101838. PubMed ID: 37995884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Noncoding Variant Near PPP1R3B Promotes Liver Glycogen Storage and MetS, but Protects Against Myocardial Infarction.
    Kahali B; Chen Y; Feitosa MF; Bielak LF; O'Connell JR; Musani SK; Hegde Y; Chen Y; Stetson LC; Guo X; Fu YP; Smith AV; Ryan KA; Eiriksdottir G; Cohain AT; Allison M; Bakshi A; Bowden DW; Budoff MJ; Carr JJ; Carskadon S; Chen YI; Correa A; Crudup BF; Du X; Harris TB; Yang J; Kardia SLR; Launer LJ; Liu J; Mosley TH; Norris JM; Terry JG; Palanisamy N; Schadt EE; O'Donnell CJ; Yerges-Armstrong LM; Rotter JI; Wagenknecht LE; Handelman SK; Gudnason V; Province MA; Peyser PA; Halligan B; Palmer ND; Speliotes EK
    J Clin Endocrinol Metab; 2021 Jan; 106(2):372-387. PubMed ID: 33231259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways.
    Pal R; Xiong Y; Sardiello M
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2977-2986. PubMed ID: 30728291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis.
    von Wilamowitz-Moellendorff A; Hunter RW; García-Rocha M; Kang L; López-Soldado I; Lantier L; Patel K; Peggie MW; Martínez-Pons C; Voss M; Calbó J; Cohen PT; Wasserman DH; Guinovart JJ; Sakamoto K
    Diabetes; 2013 Dec; 62(12):4070-82. PubMed ID: 23990365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic crosstalk: molecular links between glycogen and lipid metabolism in obesity.
    Lu B; Bridges D; Yang Y; Fisher K; Cheng A; Chang L; Meng ZX; Lin JD; Downes M; Yu RT; Liddle C; Evans RM; Saltiel AR
    Diabetes; 2014 Sep; 63(9):2935-48. PubMed ID: 24722244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.